Vicore Pharma News and Activities

Vicore Pharma is a company listed under the stock ticker VICO (SE).

View the org chart displaying its 24 main executives

Most searched biographies at Vicore Pharma

• Ahmed Mousa, Chief Executive Officer
• Heidi Hunter, Board Member
• Jacob Gunterberg, Director

Popular executive movements at Vicore Pharma

• Peter Guenter has joined the company as Director  (posted on May 8 2026).
• Bernt Van Den Blink, who was Vice President, Clinical Development, is promoted to Chief Medical Officer  (posted on March 6 2026).
• Jimmie Hofman, who was Vice President, Business Development, is promoted to Chief Business Officer  (posted on March 6 2026).

Click here to view some more movements at Vicore Pharma

Create your alert
to follow the executive moves at Vicore Pharma.

Vicore Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Vicore Pharma

• Vicore to present at the DNB Carnegie Nordic Healthcare Conference - Vicore Pharma
• Vicore to present at the Jefferies Global Healthcare Conference in London - Vicore Pharma
• Vicore Pharma intends to carry out a directed share issue - Vicore Pharma
• Vicore Pharma announces successful execution of a directed share issue of approximately USD 48 million (approximately SEK 455 million) - Vicore Pharma
• Vicore to Present at Upcoming Investor Conferences - Vicore Pharma
• Vicore announces the Nomination Committee for the 2026 Annual General Meeting - Vicore Pharma
• Interim Report July – September 2025 - Vicore Pharma
• Buloxibutid Receives Orphan Drug Designation in Japan for the Treatment of Idiopathic Pulmonary Fibrosis - Vicore Pharma
• Vicore Announces Presentations at the European Respiratory Society Congress 2025 - Vicore Pharma
• Vicore to Present at Pareto Securities' 16th Annual Healthcare Conference - Vicore Pharma
• View more press releases Close

Social media about Vicore Pharma

• Vicore Pharma on Wikipedia, Google News & Yahoo Finance
• Vicore Pharma on LinkedIn, X (Twitter) & YouTube